Seek Labs appoints Dr. Michael Paul to its Board of Directors

– USA, UT – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel CRISPR-based gene therapies, announced the appointment of Dr. Michael Paul (Ph.D.) to its Board of Directors, effective March 18, 2024, bringing industry insight and visionary leadership to accelerate Seek Labs’ growth, strategic initiatives, and research.

About Dr. Michael Paul

Dr. Michael Paul has made significant contributions to the life sciences industry through groundbreaking innovation and strategic leadership. His deep expertise in navigating the complexities of the industry, coupled with a proven track record of raising capital, driving growth, and transformation, makes Dr. Paul an invaluable addition to the Seek Labs board.

Dr. Michael Paul is CEO, President, and Director of MARAbio, a precision immunology biotechnology company that is commercializing groundbreaking technologies to detect Maternal Autoantibody Related Autism, an autoimmune subtype of autism associated with more severe forms of the condition. Before he was appointed MARAbio’s CEO, Dr. Paul co-founded Lineagen, Inc. in 2006, where he served as President, CEO, and Director from the company’s start-up to commercial growth and through its strategic acquisition in 2020. He earned a BA from Colby College and went on to earn a Ph.D. in Molecular Biology and Biochemistry from the University of Utah.

Dr. Michael Paul has been recognized as one of Utah’s leading entrepreneurs, for which he was appointed to the Utah Technology Industry Commission by former Governor Michael O. Leavitt. He has also served as Vice-Chairman for the Utah Technology Council. Dr. Paul was a finalist for E&Y’s 2018 Entrepreneur of the Year award and was named a “Utah 100 Winner” by MountainWest Capital Network.

About Seek Labs

Seek Labs is a company united by a vision to advance scientific discovery and universal solutions. Seek Labs strives to innovate healthcare solutions that bridge gaps between patients, providers, and treatments. Seek Labs is united by the passion of our founders and their shared beliefs that healthcare solutions should empower individuals and serve their specific needs. Today—after years of experimentation, failure, and breakthrough— Seek Labs is developing new solutions for point-of-care diagnostics and CRISPR-based pharmaceutical technologies that have the potential to revolutionize the detection and treatment of diseases.

Seek Labs is headquartered in Salt Lake City, Utah. Seek Labs is a proud member of the BioHive, a collective representing the life science and healthcare innovation ecosystem in Utah. BioHive is dedicated to all the ways our work can positively impact the lives of our community, our teams, and our patients.

For more information: https://seeklabs.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.